Although high doses of ADU-S100 cleared tumours, this response was not dependent on CD8+ T-cells but was rather due to an ‘ablative’ mechanism that directly caused tumour cell death, and rechallenged animals were less effective at preventing tumour development. This evidence concerns the gene CD8A and neoplasm.